Walking, easy cycling, gentle resistance training
History of pancreatitis , thyroid issues, or diabetic retinopathy, as these conditions require special consideration when prescribing GLP-1 receptor agonists
FDA-related reports and medical reviews describe BPC-157 as an unapproved peptide with limited human evidence, so human safety remains uncertain
And the chance of progressing to end-stage renal disease [ESKD] for lupus nephritis patients can be as high as 10%-30%
Robert Kushner, who helped bring them to market, breaks down how they actually work, who benefits most, and why they're a long-term commitment rather than a quick fix
doi: 10.2337/diabetes.50.8.1844 49 ArmstrongMJHullDGuoKBartonDHazlehurstJMGathercoleLLet al